Dr. Emily Albright Receives Kingston 40 Under 40 Award
- c2mci4
- Sep 4
- 2 min read
C2MCI is proud to congratulate Dr. Emily Albright of our admin team on receiving the 2025 Kingston Young Professionals 40 Under 40 Award!
Delivered annually by the Kingston Economic Development Corporation, the award celebrates individuals who have demonstrated exceptional professional achievements, community involvement, and leadership in their fields.
During her time with C2MCI, Dr. Albright has been an invaluable member of our team. Her passion for EDII led to the creation of The EDII Catalyst, a monthly podcast featuring equity-deserving persons in STEM fields, giving them an opportunity to present their lived experiences to break down barriers to understanding and create community among our network. The EDII Catalyst has been a wonderful tool that many at Queen’s and beyond are looking to for inspiration in their own networks.
Dr. Albright has championed our deserving highly qualified personnel (HQP), highlighting their strengths and assisting them in developing their potential both in the lab and outside of it. She has nominated many HQP for awards and has assisted with all our EDI Fellowship award decisions.
Over the last two years, Dr. Albright has assisted with many outreach opportunities for the C2MCI; she has led the Science Rendezvous table and expanded the McDonald Institute’s Summer of Science program to include a Chemistry component. Her enthusiasm for chemistry has generated excitement and interest in a future generation of scientists and has been a pleasure to witness.
A tireless learner, Dr. Albright has immersed herself in soft skills development. During her PhD she had the opportunity to work at Nagoya University for 3 months and is a graduate from the NSERC-CREATE program on Materials and Photonics Sensing. She has delved into the Queen’s offerings and has completed certificates on various core competencies each year since her graduation. At her final conference as a student presenter, she won an Outstanding Oral Presentation award from the Canadian Society for Chemistry.
Dr. Albright’s education has resulted in four first-author papers and one patent. She was the primary researcher on a gold nanocluster that has significant potential in cancer therapy, which is being further investigated by C2MCI collaborators at the University Health Network in Toronto. We are excited by the possibilities that this work represents and are optimistic that future cancer therapies might result from Dr. Albright's discoveries.
C2MCI is thrilled to see Dr. Albright’s remarkable contributions recognized, and we look forward to all she will continue to accomplish.
